Intravitreal Ranibizumab for Myopic Choroidal Neovascularization: 12 Months Follow-Up

被引：0
|
作者：
Papayannis, A. [1 ]
Kontadakis, D. [2 ]
Parodi, M. Battaglia [2 ]
Iacono, P. [3 ]
Sheeth, S. [1 ]
Cascavilla, M. [2 ]
Menchini, F. [1 ]
Bandello, F. [2 ]
机构：
[1] Univ Udine, Dept Ophthalmol, Udine, Italy
[2] Osped San Raffaele, Dept Ophthalmol, Milan, Italy
[3] Univ Udine, IRCCS, Fdn GB Bietti Oftalmol, Rome, Italy
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期
关键词：
choroid: neovascularization; myopia;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2223
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Single intravitreal ranibizumab for myopic choroidal neovascularization
    Nor-Masniwati, Saidin
    Shatriah, Ismail
    Zunaina, Embong
    [J]. CLINICAL OPHTHALMOLOGY, 2011, 5 : 1079 - 1082
  • [2] Intravitreal Ranibizumab for Choroidal Neovascularization Secondary to Pathological Myopia: 12-Month Follow-Up
    Lorenzo, Daniel
    Arias, Luis
    Alcubierre, Rafel
    Pujol, Octavio
    Caminal, J. M.
    Rubio, Marcos
    Catala, Jaume
    Garcia-Bru, Pere
    Arruga, Jorge
    [J]. OPHTHALMOLOGICA, 2011, 226 (03) : 103 - 109
  • [3] Comparison of Efficacy of Intravitreal Ranibizumab and Aflibercept in Eyes with Myopic Choroidal Neovascularization: 24-Month Follow-Up
    Korol, Andrii
    Kustryn, Taras
    Zadorozhnyy, Oleg
    Pasyechnikova, Natalya
    Kozak, Igor
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 36 (02) : 122 - 125
  • [4] Long-Term Follow-Up of Myopic Choroidal Neovascularization Treated with Ranibizumab
    Franqueira, Nuno
    Luz Cachulo, M.
    Pires, Isabel
    Fonseca, Pedro
    Marques, Ines
    Figueira, Joao
    Silva, Rufino
    [J]. OPHTHALMOLOGICA, 2012, 227 (01) : 39 - 44
  • [5] INTRAVITREAL RANIBIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION 12-Month Results
    Silva, Rufino M.
    Ruiz-Moreno, Jose M.
    Rosa, Paulo
    Carneiro, Angela
    Nascimento, Joao
    Rito, Luis F.
    Cachulo, M. Luz
    Carvalheira, Fausto
    Murta, Joaquim N.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (03): : 407 - 412
  • [6] INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: FOUR YEARS FOLLOW-UP
    Tilleul, Julien
    Mimoun, Gerard
    Querques, Giuseppe
    Puche, Nathalie
    Zerbib, Jennyfer
    Lalloum, Franck
    Semoun, Oudy
    Srour, Mayer
    Boulanger-Scemama, Elise
    Souied, Eric H.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [7] Intravitreal ranibizumab (Lucentis®) for the treatment of myopic choroidal neovascularization
    Lazaros Konstantinidis
    Irmela Mantel
    Jean-Antoine C. Pournaras
    Leonidas Zografos
    Aude Ambresin
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2009, 247
  • [8] Intravitreal ranibizumab (LucentisA®) for the treatment of myopic choroidal neovascularization
    Konstantinidis, Lazaros
    Mantel, Irmela
    Pournaras, Jean-Antoine C.
    Zografos, Leonidas
    Ambresin, Aude
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 247 (03) : 311 - 318
  • [9] Retinoschisis and intravitreal ranibizumab treatment for myopic choroidal neovascularization
    Huang Jianfeng
    Chen Tong
    Lu Yingyi
    Long Li
    Dai Hong
    [J]. 中华医学杂志(英文版), 2014, (11) : 2053 - 2057
  • [10] Retinoschisis and intravitreal ranibizumab treatment for myopic choroidal neovascularization
    Huang Jianfeng
    Chen Tong
    Lu Yingyi
    Long Li
    Dai Hong
    [J]. CHINESE MEDICAL JOURNAL, 2014, 127 (11) : 2053 - 2057
12345